These stories don’t just influence individual decisions; they have the power to shift perceptions, drive treatment adoption, and reignite purpose across entire organizations. The post The Most Powerful Tool in Healthcare Marketing: A Patient’s Voice appeared first on MedCity News.
Here are three things healthcare leaders should consider for improving the DME process to make the hospital-to-home experience more efficient and less stressful for all stakeholders. The post From Hospital to Home Without the Headaches: How Technology Can Smooth the Transition appeared first on MedCity News.
Los pacientes comienzan a hacer fila antes del amanecer en Operación Salud Fronteriza, una clínica de salud gratuita que se realiza cada año durante cinco días en el Valle del Río Grande de Texas. Muchos residentes de esta región predominantemente latina, ubicada en la frontera con México, no tienen seguro médico, por lo que esta…
Patients begin lining up before dawn at Operation Border Health, an annual five-day health clinic in Texas’ Rio Grande Valley. Many residents in this predominantly Latino and Hispanic region spanning the Mexican border lack insurance, making the health fair a major source of free medical care in South Texas for more than 25 years. Until…
BOWMAN, N.D. — Retta Jacobi stepped onto a metal platform that lifted her to an entrance on the side of a custom-designed semitrailer. Once inside, she lay down on a platform that technicians slid into an MRI machine. Jacobi hoped the scan would help pinpoint the source of the pain in her shoulders. The mobile…
According to new survery, over 1,700 US employers anticipate increased healthcare costs in 2026
A federal judge has allowed key claims in Particle Health’s antitrust lawsuit against Epic to move forward, marking the first time such allegations against the EHR giant have gotten this far. The case centers on Epic’s alleged use of its influence over the Carequality data exchange to block Particle’s access to patient records and stifle…
Takeda Pharmaceutical’s oveporexton is designed to treat the root cause of narcolepsy. Statistically significant Phase 3 results for the twice daily pill were presented Monday during the World Sleep 2025 Congress in Singapore. The post Takeda Is Waking Up the Narcolepsy Market With First-in-Class Drug, But Alkermes Is on Its Heels appeared first on MedCity…
WeightWatchers’ new menopause program provides support from menopause-trained clinicians, along with workshops, fitness guidance and access to prescriptions when needed. The post WeightWatchers Introduces New Menopause Program appeared first on MedCity News.
Farzad Mostashari discusses the success of the Aledade-facilitated ACOs in the MSSP